Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. percent of respondents reporting prescription use in the 2018 iteration of the CAMS survey (CAMS18).

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

APRIL 12, 2019

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) (Canadiens pour l’accès équitable à la marijuana médicale (CAEMM)) is a federal non-partisan, non-profit, patient-run organisation dedicated to protecting and improving the rights of medical cannabis patients. We don’t leave people behind under any circumstance.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”. Licensing, Agents, and Equity.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

FEBRUARY 25, 2022

Medical cannabis producers in the state had requested tax refunds in 2014 and in 2018 but the state Taxation and Revenue Department had denied those claims. New Mexico launched its medical cannabis program in 2007 and, as of January, the program had more than 130,340 enrolled patients, according to state Department of Health data.

Programs 52

Programs Collective Data Patients 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. But even with the TTOR’s focus on prevention, treatment, and recovery, illicit operations continue to wreak havoc. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

NOVEMBER 28, 2021

UK currently imports 100% of its medical cannabis, which was legalised in 2018. Self-described ‘British cannabis champion’ Equinox, which is the UK’s first ‘land-to-brand’, vertically integrated medical cannabis company, will offer retail investors the chance to access the IPO via site PrimaryBid.

Research and Development 52

Research and Development Business Cultivation Access 52

Veriheal

APRIL 24, 2023

The body of scientific evidence supporting the use of psychedelics in the treatment of PTSD, addiction, major depressive disorder, and various other mental health disorders continues to grow. However, despite the mounting data supporting their efficacy, the precise mechanism of action for psychedelics remains a mystery.

Research and Development 80

Research and Development Treatment Conditions Therapy 80

Cannabis Law Report

APRIL 21, 2022

and Canada highlights mounting cases of cannabis poisoning among pets and sheds new light on symptoms, treatments, and outcomes. Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022.

Pets 52

Pets Research and Development Topical Consumption 52

CannaMD

NOVEMBER 6, 2019

In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids. As more people gain access to medical marijuana, dependence on opioids for pain relief is likely to decline. billion opioid prescriptions written between 2011 and 2018.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In March, 2016, State Bill 307 expanded access to full-strength medical marijuana to terminally ill patients who were determined by two doctors to have less than a year to live.

Law 126

Law Marijuana Patients Treatment 126

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

PrestoDoctor

SEPTEMBER 6, 2023

One of the primary reasons for this shift is the growing acceptance and accessibility of cannabis as an alternative pain management option. In regions where medical cannabis is accessible, some studies have shown a decrease in opioid prescriptions and opioid-related fatalities.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. during the study period (2018-2030). during the study period (2018-2030). during the study period (2018-2030). during the study period (2018-2030). Analysts Insight.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. of the state’s population.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Cannabis Law Report

JANUARY 9, 2022

Of the cannabis-related tax revenue it collects, the state distributes 40% to public schools, 15% to law enforcement, and 25% to mental health and treatment programs. The city of Denver, for example, applies an additional 5.5% local sales tax on adult-use cannabis and has collected $237.5 million as of November 2021. 46,104,922. 104,759,961.

Collective 52

Collective Policy Retail Programs 52

Cannabis Law Report

SEPTEMBER 9, 2021

The collection of data for the final study was through focused interviews with a snowball sample of eight participants who have experienced trying to enter the cannabis industry in Western City, California. Data were analyzed based on the central question, and three themes emerged. Theme 3 involved access to capital.

Policy 105

Policy Research and Development Collective Banking 105

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Veriheal

OCTOBER 5, 2020

Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. According to data from another American state, Colorado, cannabis edibles account for as much as 45% of all cannabis sales – which excludes those home-made edibles made from bought or grown cannabis bud (the flower we consume).

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

OCTOBER 15, 2021

S ince 2018, the CDPH has followed FDA guidance that CBD may not be introduced to food products or dietary supplements sold in interstate commerce. . In 2018, Congress passed the 2018 federal Farm Bill that removed hemp, defined as cannabis and derivatives of cannabis with extremely low concentrations of THC (no more than 0.3%

Food 52

Food Cannabinoids Hemp Legalization 52

CannaMD

APRIL 15, 2020

To learn more about medical marijuana treatment center (MMTC) delivery services, please see: Florida Dispensaries: COVID-19 Policies. Because many of these patients are among our more vulnerable populations, it is essential that they maintain uninterrupted, regulated access to lab-tested products during this time.

Policy 55

Policy Patients Dispensary Banking 55

The Cannigma

JULY 6, 2022

A 2018 study examined 409 people who self-recorded their cannabis use to combat their insomnia and researchers found that cannabis use had “significant improvements in perceived insomnia.” Below are recommendations mostly based on extrapolated animal data and studies on essential oils from plants. ” 4.

Sleep 117

Sleep Terpenes Strains Chronic Pain 117

Cannabis Law Report

SEPTEMBER 24, 2019

Some parents, who have travelled to the Netherlands to buy cannabis medicines, feel the treatment will not help many children because it does not contain THC, which they argue has helped their children. The use of ones containing THC was legalised across the UK in November 2018. What about other medical cannabis products? PDF Version.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 30, 2019

For now, both Florida’s restrictions and federal restrictions on the scheduling of cannabis still apply as states scramble to formulate respective regulations for research, access, education, innovation. There is a distinct lack of past aggregated credible, published, accessible ongoing research or case studies. Pain Foundation.

Marijuana 40

Marijuana Education Patients Research and Development 40

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Puff Puff Post

FEBRUARY 4, 2019

Kicking any addiction requires discipline, patience and a willingness to follow a treatment plan — something that doesn’t come easily to many young people, experts said. One in 5 five high schoolers reported vaping in the last month, according to 2018 federal survey figures. E-cigarettes have become a scourge in U.S.

Vaping 101

Vaping Therapy Programs Advocacy 101

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 19, 2019

The main relevant UK legislation is the Misuse of Drugs Act 1971 (the Act) and the Misuse of Drugs Regulations 2001 (as amended by the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018) (the Regulations). No data is available regarding prescriptions written in respect of secondary care.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. pet owners spent over $70 billion in 2018 on non-CBD products for their pets.

Pets 59

Pets CBD Research and Development Epilepsy 59

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Daily cannabis consumption was an effective treatment for 85% of participants. headaches per month. headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Veriheal

SEPTEMBER 14, 2021

The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Senators Voted to Broaden Medical Cannabis Access for Veterans . Crescenz VA Medical Center.

Consumption 98

Consumption Research and Development Treatment Programs 98

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

NOVEMBER 29, 2021

ATAI Life Sciences AG (NASDAQ: ATAI), the innovative mental health platform company I have started in 2018 and which is committed to unlocking the compelling potential of psychedelics, has announced this morning that it has bought an additional stake in COMPASS Pathways (NASDAQ: CMPS), bringing atai’s ownership in Compass beyond 20%.

Treatment 52

Treatment Clinical Trials Data Patients 52